GOSS
Price
$0.71
Change
-$0.00 (-0.00%)
Updated
May 1, 6:59 PM EST
12 days until earnings call
VIR
Price
$8.74
Change
+$0.28 (+3.31%)
Updated
May 1, 6:59 PM EST
Earnings call today
Ad is loading...

Compare trend and price GOSS vs VIR

Header iconGOSS vs VIR Comparison
Open Charts GOSS vs VIRBanner chart's image
Gossamer Bio
Price$0.71
Change-$0.00 (-0.00%)
Volume$655.88K
CapitalizationN/A
Vir Biotechnology
Price$8.74
Change+$0.28 (+3.31%)
Volume$1.06M
CapitalizationN/A
View a ticker or compare two or three
GOSS vs VIR Comparison Chart

Loading...

GOSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GOSS vs. VIR commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and VIR is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (GOSS: $0.70 vs. VIR: $8.75)
Brand notoriety: GOSS and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 69% vs. VIR: 140%
Market capitalization -- GOSS: $159.42M vs. VIR: $1.19B
GOSS [@Biotechnology] is valued at $159.42M. VIR’s [@Biotechnology] market capitalization is $1.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $578.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileVIR’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • VIR’s FA Score: 0 green, 5 red.
According to our system of comparison, VIR is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 4 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • GOSS’s TA Score: 4 bullish, 4 bearish.
  • VIR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both GOSS and VIR are a good buy in the short-term.

Price Growth

GOSS (@Biotechnology) experienced а -0.51% price change this week, while VIR (@Biotechnology) price change was +8.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.39%. For the same industry, the average monthly price growth was -4.43%, and the average quarterly price growth was +1237.50%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 06, 2024.

VIR is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+3.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for GOSS with price predictions.
OPEN
A.I.dvisor published
a Summary for VIR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VIR($1.19B) has a higher market cap than GOSS($159M). VIR YTD gains are higher at: -13.022 vs. GOSS (-22.773).
GOSSVIRGOSS / VIR
Capitalization159M1.19B13%
EBITDAN/AN/A-
Gain YTD-22.773-13.022175%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
GOSSVIR
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 1 day ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
GOSSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LCMRX34.490.04
+0.12%
ClearBridge Mid Cap Growth R
DGIGX40.670.04
+0.10%
BNY Mellon Appreciation I
AFAVX13.35-0.04
-0.30%
AMG River Road Focused Absolute Value I
TRTZX33.04-0.18
-0.54%
T. Rowe Price Mid-Cap Value Z
VNSNX20.12-0.14
-0.69%
Natixis Vaughan Nelson Select N